Lung cancer: A deadly disease
Lung cancer is the most deadly form of cancer. Less than 10% of people diagnosed with lung cancer live for more than five years post diagnosis. Every year lung cancer causes 1.7 million deaths globally, around 270,000 of them in the EU. Worldwide almost a fifth of all cancer related deaths, stem from the lung. That's why specialists are eagerly looking for ways to detect this disease as early as possible.learn more
What we offer
Why volumetry screening?
Recent European lung cancer studies have shown that CT lung cancer screening can detect lung cancer at a very early stage, and early detection of lung cancer can dramatically reduce the mortality rate among lung cancer patients. Not only the moment at which the screening takes place is relevant, but the accuracy of the professional interpreting the screening is imperative. Leading lung cancer specialists from eight European countries therefore urge EU countries to set up life-saving lung cancer screening programs as quickly as possible. This position paper regarding advice for lung cancer screening was published in the Lancet Oncology (Oudkerk et. al, Lancet 2017).
One of the most important studies upon which this training is based is the Dutch NELSON study (Oudkerk et. al, Lancet 2017). Preliminary findings suggest an urgency to develop national screening programs. American research (NLST, Pats et.al, 2016) has concurrently shown that screening at an early stage significantly increases the chances for survival among long cancer patients. In short, these studies reach the same basic conclusion: early and accurate lung cancer screening saves lives.
Stay in touch
Get all the latest information about the study and new training programs